AURORA MEDCARE — All Prescriptions & Medications — Page 4
Practice Code: F82042 | BARKING, IG11 0LG
Showing results 151-200 of 636
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 331 | 174.6K | £1.4K | +263.0% ▲ | |
| Chlorphenamine maleate | 330 | 39.7K | £1.1K | +199.0% ▲ |
| Clobetasol propionate | 328 | 31.8K | £2.5K | +140.4% ▲ |
| Moxonidine | 323 | 10.1K | £1.5K | +480.2% ▲ |
| Fluticasone propionate (Nasal) | 322 | 978 | £4.0K | +121.2% ▲ |
| Orlistat | 321 | 30.2K | £7.2K | +289.4% ▲ |
| Pravastatin sodium | 318 | 10.9K | £507 | -2.1% ▼ |
| Pantoprazole | 316 | 11.1K | £534 | +15.0% ▲ |
| Canagliflozin | 310 | 8,004 | £10.0K | +115.9% ▲ |
| 306 | 30.9K | £3.3K | +259.4% ▲ | |
| Oxybutynin | 301 | 15.2K | £3.6K | +58.0% ▲ |
| Dorzolamide and timolol | 298 | 9,045 | £5.7K | +108.2% ▲ |
| Dexamethasone | 293 | 3,318 | £2.2K | +390.7% ▲ |
| 287 | 487 | £504 | +30.2% ▲ | |
| Estradiol with progestogen | 286 | 7,912 | £7.9K | -16.1% ▼ |
| Calcipotriol | 283 | 28.7K | £16.5K | +66.2% ▲ |
| Sacubitril/valsartan | 279 | 15.3K | £25.1K | +16.5% ▲ |
| Mesalazine (Systemic) | 278 | 29.8K | £13.6K | +16.1% ▲ |
| Mometasone furoate | 276 | 22.9K | £2.2K | +106.4% ▲ |
| 274 | 14.7K | £776 | +404.8% ▲ | |
| Mebeverine hydrochloride | 271 | 24.5K | £817 | -12.7% ▼ |
| Finasteride | 269 | 8,064 | £293 | -58.9% ▼ |
| Clotrimazole | 268 | 2,323 | £2.0K | +142.9% ▲ |
| Fusidic acid | 267 | 6,390 | £795 | +109.1% ▲ |
| Medroxyprogesterone acetate | 265 | 265 | £1.5K | +119.5% ▲ |
| Fluticasone furoate | 265 | 297 | £1.9K | +36.8% ▲ |
| Ivabradine | 264 | 8,288 | £2.3K | +177.7% ▲ |
| Cyanocobalamin | 264 | 15.1K | £1.4K | -25.2% ▼ |
| Digoxin | 262 | 6,438 | £482 | -30.8% ▼ |
| Hydroxyzine hydrochloride | 261 | 6,006 | £186 | +390.0% ▲ |
| Ranolazine | 260 | 11.1K | £2.0K | +53.0% ▲ |
| Dihydrocodeine tartrate | 260 | 11.6K | £1.1K | +33.1% ▲ |
| Insulin degludec | 255 | 1,266 | £13.0K | +132.0% ▲ |
| Bimatoprost | 254 | 5,172 | £3.5K | +70.9% ▲ |
| Letrozole | 243 | 7,112 | £668 | +30.1% ▲ |
| Etoricoxib | 241 | 6,594 | £1.9K | +199.1% ▲ |
| Urea | 241 | 126.4K | £4.6K | +260.7% ▲ |
| Diltiazem hydrochloride | 240 | 10.9K | £1.6K | -21.8% ▼ |
| Dexamethasone | 238 | 1,335 | £832 | +38.4% ▲ |
| Sulfasalazine | 234 | 20.8K | £2.2K | +79.8% ▲ |
| Paroxetine hydrochloride | 234 | 5,506 | £358 | +25.4% ▲ |
| Nicorandil | 230 | 8,230 | £1.3K | +59.8% ▲ |
| Clonazepam | 230 | 6,544 | £1.1K | +47.6% ▲ |
| Ketoconazole | 230 | 37.9K | £6.9K | +134.2% ▲ |
| Lacosamide | 229 | 4,816 | £2.8K | +326.1% ▲ |
| Hyoscine butylbromide | 225 | 12.5K | £868 | -3.5% ▼ |
| Alfacalcidol | 224 | 9,000 | £2.0K | +81.1% ▲ |
| Isophane insulin | 222 | 1,205 | £5.2K | +110.3% ▲ |
| Carvedilol | 221 | 9,443 | £369 | +94.8% ▲ |
| Labetalol hydrochloride | 221 | 11.2K | £1.6K | +873.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.